Galactose Intolerance or Lapp Lactase Deficiency
Avoid the use of this medicine in patients with family history of galactose intolerance or Lapp lactase deficiency.
Use of Atorvastatin in Diabetic Patients
The patients with fasting glucose levels in between 5.6 to 6.9 mmol/L, body mass index more than 30kg/m2, high levels of triglycerides
and high blood pressure conditions are at an increased risk when using this medicine. Careful monitoring is required in such patients.
The patients using Atorvastatin for the long term may be at increased risk. These patients may have an increased risk of interstitial lung disease which is characterized by symptoms like shortness of breath, cough
, weight loss and fatigue
. If it happens, discontinue the use of this medicine.
These patients may have increased levels of glucose in the blood. This medicine should be used with caution in such patients.
Temporary Blockage of Blood Flow to the Brain
Such patients are at an increased risk when using this medicine. These patients may have an increased risk of bleeding
inside the brain due to rupturing of blood vessels (hemorrhagic stroke
). Take necessary precautions before starting this therapy.
Abnormal Functioning of the Liver
Such patients are at an increased risk when using this medicine. These patients may have increased levels of liver transaminases enzymes. This medicine should be used only after testing the levels of liver enzymes.
Skeletal Muscle Defects
Use of this medicine may lead to increased risk of muscle pain
, inflammation of the muscles and damaging of skeletal muscles. Such patients may have an increased risk of kidney failure. Discontinue the use of Atorvastatin for the treatment of muscular diseases.